DDH TREATMENT OPTIONS
Age-Dependent Management | AVN Prevention Critical | Early Diagnosis Essential | 95% Success with Pavlik
AGE-BASED TREATMENT
Critical Must-Knows
- Age determines treatment: 0-6mo = Pavlik, 6-18mo = closed reduction, 18mo-3yr = open reduction, over 3yr = open reduction + osteotomy
- AVN is most devastating complication - always results from treatment, not disease. Prevention: avoid forced abduction over 55°, human position in spica
- Pavlik harness positioning: Flexion 100-110°, abduction 50-70°, wear 23 hours/day, monitor with ultrasound every 3-4 weeks
- Safe zone concept: Range between redislocation and AVN risk positions. Must be at least 25° for closed reduction to succeed
- Graf ultrasound classification: Type I (normal), II (immature/dysplastic), III (subluxed), IV (dislocated)
Examiner's Pearls
- "Know age-based treatment algorithm - examiners frequently test this
- "AVN prevention is key - describe human position (100° flexion, 40-50° abduction, neutral rotation)
- "Pavlik harness failure: discontinue if not reduced by 3-4 weeks to prevent AVN
- "Obstacles to reduction: psoas, ligamentum teres, pulvinar, limbus, transverse acetabular ligament, capsule, adductors
Clinical Imaging
Imaging Gallery


Critical DDH Treatment Exam Points
Age Determines Treatment
Treatment is age-dependent. 0-6 months: Pavlik harness (95% success). 6-18 months: Closed reduction + spica. 18 months-3 years: Open reduction. Over 3 years: Open reduction + osteotomy. Never use Pavlik over 6-7 months.
AVN Prevention is Critical
AVN always results from treatment, not disease. Prevention: avoid abduction over 55°, use human position in spica (100° flexion, 40-50° abduction, neutral rotation), discontinue Pavlik if not reduced by 3-4 weeks. AVN rates: Pavlik 5-10%, closed reduction 20%, open reduction 10-20%.
Pavlik Harness Principles
Positioning: Flexion 100-110° (anterior strap), abduction 50-70° (posterior strap). Wear 23 hours/day initially. Monitor with ultrasound every 3-4 weeks. Discontinue if not reduced by 3-4 weeks (AVN risk increases).
Safe Zone Concept
Safe zone: Range between redislocation and AVN risk positions. Must be at least 25° for closed reduction to succeed. Assessed with arthrogram during EUA. Adductor tenotomy widens safe zone if narrow.
DDH Treatment by Age - Quick Reference
| Age Group | Treatment | Key Principles | Success Rate |
|---|---|---|---|
| 0-6 months | Pavlik harness | Flexion 100-110°, abduction 50-70°, monitor with USS | 95% success |
| 6-18 months | Closed reduction + spica | EUA with arthrogram, safe zone over 25 degrees, human position | 80-90% success |
| 18 months-3 years | Open reduction | Medial (under 12mo) or anterior (over 12mo) approach | 85-90% success |
| Over 3 years | Open reduction + osteotomy | Femoral shortening/varus + pelvic osteotomy | 70-80% success |
BREECHDDH Risk Factors
Memory Hook:BREECH babies and females are at highest risk for DDH!
PLACTSObstacles to Reduction
Memory Hook:PLACTS - all obstacles must be addressed for successful reduction!
FLEX ABDPavlik Harness Positioning
Memory Hook:FLEX ABD - proper positioning prevents AVN and ensures success!
Overview and Epidemiology
Why This Topic Matters
Developmental dysplasia of the hip is the most common hip disorder in infants. Early diagnosis and age-appropriate treatment are essential to prevent long-term disability, AVN, and early osteoarthritis. Understanding the age-based treatment algorithm and AVN prevention strategies is critical for exam success.
Epidemiology
- Incidence: 1 in 1000 live births
- Gender: Female predominance 7:1 (relaxin sensitivity)
- Laterality: Left hip 60% (fetal position), bilateral 20%
- Risk factors: Breech (20% vs 2% population), family history (12%), firstborn, packaging disorders
- Ethnicity: Higher in Caucasian, Lapland, Native American populations
Natural History
- 1 in 60 abnormal at birth but 60% stabilize by 1 week, 88% by 2 months
- Untreated DDH: Leads to abnormal gait, limb shortening, early osteoarthritis
- Early treatment: Excellent outcomes with 95% success in Pavlik harness
- Late treatment: Worse outcomes, higher AVN risk, may require multiple surgeries
Pathophysiology and Mechanisms
Pathoanatomy of DDH
DDH represents a spectrum from mild acetabular dysplasia to complete dislocation. Pathoanatomy includes: shallow acetabulum, labral hypertrophy and inversion, capsular laxity, ligamentum teres elongation, pulvinar (fibrofatty tissue) development in acetabulum, and secondary femoral head changes. Understanding these changes guides treatment approach.
| Structure | Normal | DDH Changes | Clinical Significance |
|---|---|---|---|
| Acetabulum | Deep, covers 50%+ of head | Shallow, covers less than 50% | Reduced coverage, instability |
| Labrum | Normal size, everted | Hypertrophied, inverted | Blocks reduction, requires release |
| Capsule | Normal tension | Lax, hourglass constriction | Prevents reduction, requires release |
| Ligamentum teres | Normal size | Elongated, hypertrophied | Obstacle to reduction, excise |
| Pulvinar | Minimal | Fibrofatty tissue in acetabulum | Obstacle to reduction, excise |
| Femoral head | Spherical, centered | May be flattened, displaced | Secondary changes from dislocation |
Acetabular Development
- Normal: Acetabular index 30° at birth, decreases to 20° by 24 months
- DDH: Elevated acetabular index, shallow acetabulum
- Remodeling potential: Up to 5 years of age
- After 5 years: Limited remodeling, may need osteotomy
Femoral Head Changes
- Early: May be normal if recently dislocated
- Chronic: Flattening, loss of sphericity
- Ossification: Delayed in dislocated hip
- After reduction: May remodel if reduced early
Classification Systems

Graf Classification (Ultrasound)
| Graf Type | Alpha Angle | Beta Angle | Description | Treatment |
|---|---|---|---|---|
| Type I | Over 60° | Under 60° | Normal hip | Observation |
| Type II | 43-60° | 55-77° | Immature or dysplastic | Monitor or Pavlik |
| Type III | Under 43° | Over 77° | Subluxed | Pavlik harness |
| Type IV | Under 43° | Over 77° | Dislocated | Pavlik harness |
Graf Classification Key Points
Alpha angle (bony acetabular coverage): Normal over 60°. Beta angle (cartilaginous coverage): Normal under 60°. Type III and IV require treatment with Pavlik harness. Ultrasound is imaging modality of choice under 4-6 months (cartilaginous head not visible on X-ray).
Clinical Assessment
Neonatal Examination
- Ortolani test: Abduction and gentle pressure over GT - clunk indicates reduction
- Barlow test: Adduction and posterior pressure - clunk indicates subluxation
- Reliability: Unreliable after 2-3 months as soft tissues tighten
- Other signs: Asymmetric creases, limited abduction (under 60°), Galeazzi sign (unilateral only)
Older Infant/Child
- Limited abduction: Primary sign after 3 months
- Limb length discrepancy: Unilateral cases
- Gait abnormality: Waddling gait in bilateral, Trendelenburg in unilateral
- Asymmetric skin creases: May be present but not diagnostic
Clinical Examination Findings
| Age | Key Findings | Tests | Reliability |
|---|---|---|---|
| 0-3 months | Ortolani/Barlow positive | Ortolani, Barlow tests | Reliable |
| 3-12 months | Limited abduction | Abduction ROM, Galeazzi sign | Moderately reliable |
| Over 12 months | Limp, LLD, limited ROM | Gait assessment, ROM | Less reliable - imaging key |
Investigations
Ultrasound (Under 4-6 Months):
- Timing: Most useful from 4-6 weeks until femoral head ossifies
- Graf classification: Alpha angle (bony coverage, normal over 60°), beta angle (cartilaginous, normal under 60°)
- Dynamic assessment: Evaluates stability during movement
- Monitoring: Repeat every 3-4 weeks during Pavlik treatment
Radiographs (Over 4-6 Months):
- AP pelvis: Assess acetabular index, Shenton's line, head position
- Frog-leg lateral: Assess femoral head coverage, version
- Measurements: Acetabular index (normal under 30° at 1 year), center-edge angle (after age 5)
Arthrogram (During EUA for Closed Reduction):
- Normal findings: Sharp labrum (rose thorn sign), minimal medial pooling
- Abnormal findings: Widened medial joint space (pooling over 5mm), blunted labrum, hourglass constriction
- Safe zone assessment: Determines abduction range maintaining reduction without AVN risk
Management Algorithm
Treatment Algorithm by Age
0-6 Months: Pavlik Harness
- First-line treatment for dislocatable/dislocated hips
- Positioning: Flexion 100-110°, abduction 50-70°
- Wear 23 hours/day initially, wean over 2-4 months
- Monitor with ultrasound every 3-4 weeks
- Success rate: 95% for Graf III/IV detected early
- Discontinue if not reduced by 3-4 weeks (AVN risk)
6-18 Months: Closed Reduction
- Examination under anaesthesia with arthrogram
- Assess reduction quality and safe zone
- Adductor tenotomy if safe zone narrow (under 25°)
- Spica cast: 100° flexion, 40-50° abduction, neutral rotation
- Cast for 3 months, change at 6 weeks
- Success rate: 80-90% if adequate safe zone
18 Months-3 Years: Open Reduction
- Indicated when closed reduction fails
- Medial approach (Ludloff, Ferguson) under 12 months
- Anterior approach (Smith-Petersen) over 12 months
- Address obstacles to reduction
- May need femoral shortening if tight
Over 3 Years: Open Reduction + Osteotomy
- Open reduction always required
- Femoral varus and shortening osteotomy
- Pelvic osteotomy for residual dysplasia
- More complex, higher complication risk
This age-based approach ensures optimal outcomes while minimizing complications.
Surgical Technique

Pavlik Harness Application
Indications:
- Graf Type III or IV (subluxed or dislocated)
- Age 0-6 months (maximum 6-7 months)
- Dislocatable hip on examination
Application:
- Chest strap: Around nipple line, snug but not tight
- Anterior strap: Controls flexion 100-110°
- Posterior strap: Controls abduction 50-70°
- Positioning: Hip flexed and abducted, allows active motion
Monitoring:
- Ultrasound every 3-4 weeks
- Check for reduction, assess Graf type improvement
- Adjust straps as needed
Discontinuation:
- If reduced: Gradually wean over 2-4 months
- If not reduced by 3-4 weeks: Discontinue to prevent AVN
- Switch to closed reduction if Pavlik fails
Complications:
- AVN (5-10%): From forced abduction, discontinue if not reduced
- Pavlik disease: Posterolateral acetabular wear from treatment in unreduced position
- Recurrence: ~10% after successful treatment
Proper application and monitoring are essential for success and AVN prevention.
Complications
Avascular Necrosis (Most Devastating)
Incidence:
- Pavlik harness: 5-10%
- Closed reduction: ~20% (Salter type 1)
- Open reduction: 10-20% (medial approach 10%, anterior approach 10-20%)
Causes:
- Always results from treatment, not disease
- Forced abduction over 55°
- Extreme abduction with internal rotation and extension
- Multiple reduction attempts
- Early rigid casting
Kalamchi-MacEwen Classification:
- Class I: Nucleus only - will be normal
- Class II: Lateral physis - coxa valga from lateral physeal fusion
- Class III: Central - moderate deformity
- Class IV: Whole physis - severe deformity, poor outcomes
Prevention:
- Avoid abduction over 55°
- Use human position in spica (100° flexion, 40-50° abduction, neutral rotation)
- Discontinue Pavlik if not reduced by 3-4 weeks
- Gentle reduction technique
- Avoid multiple reduction attempts
Management:
- Established AVN: Containment procedures, may need later salvage
- Monitor for growth disturbance, coxa magna, coxa breva, coxa vara
AVN prevention is the most important principle in DDH treatment.
Postoperative Care
Pavlik Harness:
- Wear 23 hours/day initially
- Gradually wean over 2-4 months as hip stabilizes
- Monitor with ultrasound every 3-4 weeks
- Discontinue if not reduced by 3-4 weeks
- Parent education on application and care
Spica Cast (Closed Reduction):
- Duration: 3 months
- Change cast at 6 weeks
- Immediate MRI in spica to confirm reduction
- Cast care: Keep dry, check for pressure areas
- Monitor for cast problems, skin issues
Open Reduction:
- Spica cast for 3 months postoperatively
- Change cast at 6 weeks
- Monitor for AVN with serial radiographs
- Physiotherapy after cast removal
- Long-term follow-up for residual dysplasia
Long-term Follow-up:
- Serial radiographs: 6 months, 1 year, 2 years, then annually until skeletal maturity
- Monitor for AVN, residual dysplasia, redislocation
- Acetabular index should normalize by age 2-3 years
- Center-edge angle assessment after age 5
Follow-up Key Points
Long-term follow-up is essential to monitor for AVN (may present late), residual dysplasia (may need later osteotomy), and redislocation. Serial radiographs monitor acetabular development and femoral head shape.
Outcomes and Prognosis
Early Treatment Outcomes
- Pavlik harness: 95% success if detected early (under 6 weeks)
- Closed reduction: 80-90% success if adequate safe zone
- Open reduction: 85-90% success
- Key factor: Early diagnosis and treatment
Late Treatment Outcomes
- Over 3 years: 70-80% success, higher complication rates
- Over 5 years: Limited remodeling potential
- Bilateral painless dislocations: May leave alone (controversial)
- Late diagnosis: Correlates with worse outcomes
Outcomes by Treatment Modality
| Treatment | Success Rate | AVN Risk | Key Factors |
|---|---|---|---|
| Pavlik (0-6mo) | 95% | 5-10% | Early detection, proper positioning |
| Closed reduction (6-18mo) | 80-90% | 20% | Adequate safe zone, human position |
| Open reduction (18mo-3yr) | 85-90% | 10-20% | Address all obstacles, gentle technique |
| Open reduction + osteotomy (over 3yr) | 70-80% | 15-25% | Complex, higher risk |
Evidence Base
Pavlik Harness Effectiveness
- 95% success rate for early treatment (under 6 weeks)
- Success drops to 80% if started after 7 weeks
- AVN rate 5-10% with proper positioning
- Discontinue if not reduced by 3-4 weeks to prevent AVN
AVN Prevention in DDH
- Human position reduces AVN risk
- Abduction over 55° significantly increases AVN risk
- Neutral rotation important for AVN prevention
- Gentle reduction technique essential
Open Reduction Outcomes
- 85-90% success rate before age 3 years
- Success decreases with increasing age
- AVN risk 10-20% depending on approach
- Addressing all obstacles to reduction improves outcomes
Long-term Outcomes of Treated DDH
- Early treatment produces excellent long-term outcomes
- Low osteoarthritis risk with early treatment
- Late diagnosis increases OA risk even after treatment
- Emphasizes importance of early diagnosis
Acetabular Remodeling Potential
- Remodeling potential up to 5 years of age
- Limited remodeling after age 5
- Osteotomy may be required for residual dysplasia
- Serial monitoring essential to assess remodeling
Exam Viva Scenarios
Practice these scenarios to excel in your viva examination
Pavlik Harness Management
"A 3-month-old infant presents with Graf Type IV DDH (dislocated hip). You decide to use Pavlik harness. Describe your management approach including positioning, monitoring, and when you would discontinue treatment."
Closed Reduction Decision
"An 8-month-old infant with DDH failed Pavlik harness treatment. You perform examination under anaesthesia with arthrogram. The arthrogram shows medial pooling of 8mm and a safe zone of only 15°. Discuss your management."
Older Child DDH
"A 2.5-year-old child presents with untreated unilateral DDH. The hip is dislocated and irreducible. Discuss your management approach including surgical technique and expected outcomes."
MCQ Practice Points
Pavlik Harness Success Rate
Q: What is the success rate of Pavlik harness for Graf Type III/IV DDH when initiated early (under 6 weeks)? A: 95% - Pavlik harness achieves 95% success rate when initiated early. Success drops to 80% if started after 7 weeks.
Most Devastating Complication
Q: The most devastating complication of DDH treatment is: A: Avascular necrosis (AVN) - AVN is the most devastating complication, causing femoral head deformity and growth disturbance. It always results from treatment, not disease.
Maximum Abduction Angle
Q: What is the maximum abduction angle in spica cast to minimize AVN risk? A: 55° - Abduction over 55° significantly increases AVN risk. Human position uses 40-50° abduction to minimize risk.
Acetabular Remodeling Potential
Q: At what age does acetabular remodeling potential significantly decrease? A: 5 years - Acetabular remodeling potential exists up to 5 years. After this, limited remodeling occurs and osteotomy may be required.
Open Reduction Approach
Q: Which approach is preferred for open reduction of DDH in a 10-month-old child? A: Medial approach (Ludloff/Ferguson) - Preferred under 12 months as it preserves blood supply and has lower AVN risk (10% vs 10-20% for anterior).
Safe Zone for Closed Reduction
Q: What is the minimum safe zone required for successful closed reduction? A: 25° - Safe zone under 25° is associated with high failure and AVN risk. Adductor tenotomy may widen safe zone.
Australian Context
Australian Screening Practices
- Universal clinical screening: Standard in Australia
- Selective ultrasound: For at-risk infants (breech, family history, abnormal exam)
- Universal ultrasound: Controversial - high false-positive rate, overtreatment concerns
- Screening effectiveness: Has not significantly reduced late diagnosis rates
Healthcare System
- Public system: DDH treatment available, may have wait times
- Private system: Faster access, specialized pediatric orthopaedic surgeons
- Follow-up: Requires long-term surveillance in both systems
- Cost: Early treatment (Pavlik) much less expensive than late treatment (surgery)
Australian Exam Context
Australian examiners may ask about screening programs, cost-effectiveness of early vs late treatment, and resource allocation. Know that selective ultrasound screening is common practice, and emphasize cost-effectiveness of early treatment (Pavlik) compared to late treatment (surgery).
DDH TREATMENT OPTIONS
High-Yield Exam Summary
Age-Based Treatment Algorithm
- •0-6 months: Pavlik harness (95% success if early)
- •6-18 months: Closed reduction + spica (80-90% success)
- •18 months-3 years: Open reduction (85-90% success)
- •Over 3 years: Open reduction + osteotomy (70-80% success)
Pavlik Harness Management
- •Positioning: Flexion 100-110°, abduction 50-70°
- •Wear: 23 hours/day initially
- •Monitoring: Ultrasound every 3-4 weeks
- •Discontinue if not reduced by 3-4 weeks (prevents AVN)
- •Success rate: 95% if detected early (under 6 weeks)
AVN Prevention - Critical Principles
- •Human position: 100° flexion, 40-50° abduction, neutral rotation
- •Never exceed 55° abduction (significantly increases AVN risk)
- •Gentle reduction - forced reduction causes AVN
- •Discontinue Pavlik promptly if reduction fails
- •AVN always results from treatment, not disease
Safe Zone and Closed Reduction
- •Safe zone: Range between redislocation and AVN risk
- •Minimum 25° required for closed reduction success
- •Medial pooling over 7mm = poor outcome predictor
- •Adductor tenotomy may widen safe zone
- •If safe zone inadequate after tenotomy → open reduction
Obstacles to Reduction
- •Psoas tendon (release)
- •Ligamentum teres (excise)
- •Pulvinar (excise)
- •Inverted limbus (may need release)
- •Transverse acetabular ligament (release)
- •Capsule hourglass constriction (incise)
- •Adductors (tenotomy)
Graf Classification
- •Type I: Normal (alpha over 60°, beta under 60°)
- •Type II: Immature (may resolve)
- •Type III: Subluxed (needs treatment)
- •Type IV: Dislocated (needs treatment)
- •Ultrasound under 4-6 months (cartilaginous head)
Open Reduction Approaches
- •Medial approach (Ludloff/Ferguson): Under 12 months, 10% AVN risk
- •Anterior approach (Smith-Petersen): Over 12 months, 10-20% AVN risk
- •Medial preserves blood supply better in infants
- •Anterior allows pelvic osteotomy if needed
Pelvic Osteotomies
- •Salter: Redirectional, young children
- •Pemberton: Reshaping, under 8 years
- •PAO (Periacetabular Osteotomy): Adolescent/adult
- •Indicated if acetabular index over 30° or center-edge angle under 20°
AVN Rates by Treatment
- •Pavlik harness: 5-10%
- •Closed reduction: 20%
- •Open reduction: 10-20%
- •Late presentation: Higher complication rates
- •AVN is most devastating complication
Key Principles
- •Early diagnosis and treatment essential
- •95% success with Pavlik if detected early
- •Age-based treatment algorithm critical
- •AVN prevention is paramount
- •Address all obstacles to reduction